Catalyst
Slingshot members are tracking this event:
Data read out from ALKS 5461 FORWARD-4 trial in Treatment Resistant Depression the first of 3 Phase 3 trials currently underway
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 21, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2131031
Related Projects
Related Keywords
Treatment Resistant Depression, Trd, Alks-5461, Phase 3
